GENFLEET-B (02595) Schedules 24 Mar 2026 Board Meeting to Approve FY2025 Results and Final Dividend Proposal

Bulletin Express

Mar 12

GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 02595), a joint-stock company incorporated in the PRC, has announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s primary agenda includes:

• Approval and publication of the consolidated annual results for the financial year ended 31 December 2025. • Consideration of a recommendation regarding the payment of a final dividend, if any.

The announcement was released in Hong Kong on 12 March 2026.

Board composition at the date of the notice is as follows: Executive Directors – Dr. Qiang Lu (Chairman), Dr. Jiong Lan, and Ms. Zhang Wei; Non-Executive Directors – Mr. Zhu Jingyang and Ms. Tao Sha; Independent Non-Executive Directors – Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, and Mr. Li Bo.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1116262730"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1116262730\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1116262730?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 06:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116262730","market":"hk","top_or_hot":-1,"title":"GENFLEET-B (02595) Schedules 24 Mar 2026 Board Meeting to Approve FY2025 Results and Final Dividend Proposal","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 02595), a joint-stock company incorporated in the PRC, has announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s primary agenda includes:</p>\n<p>• Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n• Consideration of a recommendation regarding the payment of a final dividend, if any.</p>\n<p>The announcement was released in Hong Kong on 12 March 2026.</p>\n<p>Board composition at the date of the notice is as follows: Executive Directors – Dr. Qiang Lu (Chairman), Dr. Jiong Lan, and Ms. Zhang Wei; Non-Executive Directors – Mr. Zhu Jingyang and Ms. Tao Sha; Independent Non-Executive Directors – Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, and Mr. Li Bo.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GENFLEET-B (02595) Schedules 24 Mar 2026 Board Meeting to Approve FY2025 Results and Final Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGENFLEET-B (02595) Schedules 24 Mar 2026 Board Meeting to Approve FY2025 Results and Final Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-12 06:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 02595), a joint-stock company incorporated in the PRC, has announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s primary agenda includes:</p>\n<p>• Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n• Consideration of a recommendation regarding the payment of a final dividend, if any.</p>\n<p>The announcement was released in Hong Kong on 12 March 2026.</p>\n<p>Board composition at the date of the notice is as follows: Executive Directors – Dr. Qiang Lu (Chairman), Dr. Jiong Lan, and Ms. Zhang Wei; Non-Executive Directors – Mr. Zhu Jingyang and Ms. Tao Sha; Independent Non-Executive Directors – Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, and Mr. Li Bo.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1116262730","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116262730","pubTimestamp":1773267756,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 02595), a joint-stock company incorporated in the PRC, has announced that its board of directors will convene on Tuesday, 24 March 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GENFLEET-B(02595)定于2026年3月24日召开董事会批准2025财年业绩和末期股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. (Stock Code: 02595), a joint-stock company incorporated in the PRC, has announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s primary agenda includes:\n• Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n• Consideration of a recommendation regarding the payment of a final dividend, if any.\nThe announcement was released in Hong Kong on 12 March 2026.\nBoard composition at the date of the notice is as follows: Executive Directors – Dr. Qiang Lu (Chairman), Dr. Jiong Lan, and Ms. Zhang Wei; Non-Executive Directors – Mr. Zhu Jingyang and Ms. Tao Sha; Independent Non-Executive Directors – Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, and Mr. Li Bo.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}